Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance (Q36021050)

11 August 2017

1 reference

title

Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance (English)

1 reference

11 August 2017

main subject

Pseudomonas aeruginosa

0 references

author name string

Alan R Hauser

series ordinal

1

1 reference

11 August 2017

Padman Sriram

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 August 2017

published in

Postgraduate Medicine

1 reference

11 August 2017

volume

117

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

41-48

1 reference

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

Colistin: an antimicrobial for the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2005.01.1571

21 January 2018

Identifiers

DOI

10.3810/PGM.2005.01.1571

1 reference

11 August 2017

1 reference